α-1 Antitrypsin binds preprohepcidin intracellularly and prohepcidin in the serum

FEBS Journal

Volumn 276, Issue 7, 2009, Pages 2012-2021

  Pandur, Edina ^a   Nagy, Judit ^a   Poór, Viktor S ^a   Sarnyai, Ákos ^a   Huszár, András ^a   Miseta, Attila ^a   Sipos, Katalin ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

1 antitrypsin; Blood serum; Cellular transport; Hepcidin; Iron transport

Indexed keywords

ALPHA 1 ANTITRYPSIN; HEPCIDIN; OROSOMUCOID; PEPTIDE HORMONE; PREALBUMIN; PREPROHEPCIDIN; PROHEPCIDIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BLOOD LEVEL; CELL TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; IRON TRANSPORT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION;

ALPHA 1-ANTITRYPSIN; ANTIMICROBIAL CATIONIC PEPTIDES; BINDING SITES; CELL LINE, TUMOR; HUMANS; MASS SPECTROMETRY; PROTEIN PRECURSORS;

EID: 62149129583     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.06937.x     Document Type: Article

References (42)

1. Ganz T Nemeth E (2006) Regulation of iron acquisition and iron distribution in mammals. Biochim Biophys Acta 1763, 690 699.
2. Hentze MW, Muckenthaler MU Andrews NC (2004) Balancing acts: molecular control of mammalian iron metabolism. Cell 117, 285 297.
3. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, Goldberg YP, Sakellaropoulos N, Ganz T Nemeth E (2005) Hepcidin in iron overload disorders. Blood 105, 4103 4105.
4. Beutler E (2007) Iron storage disease: facts, fiction and progress. Blood Cells Mol Dis 39, 140 147.
5. Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102, 783 788.
6. Robson KJ, Merryweather-Clarke AT, Cadet E, Viprakasit V, Zaahl MG, Pointon JJ, Weatherall DJ Rochette J (2004) Recent advances in understanding haemochromatosis: a transition state. J Med Genet 41, 721 730.
7. Dunn LL, Rahmanto YS Richardson DR (2007) Iron uptake and metabolism in the new millennium. Trends Cell Biol 17, 93 100.
8. Swinkels DW, Janssen MC, Bergmans J Marx JJ (2006) Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clin Chem 52, 950 968.
9. Courselaud B, Pigeon C, Inoue Y, Inoue J, Gonzalez FJ, Leroyer P, Gilot D, Boudjema K, Guguen-Guillouzo C, Brissot P et al. (2002) C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem 277, 41163 41170.
10. Verga Falzacappa MV Muckenthaler MU (2005) Hepcidin: iron-hormone and anti-microbial peptide. Gene 364, 37 44.
11. Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A Vaulont S (2002) Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 29, 327 335.
12. Park CH, Valore EV, Waring AJ Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276, 7806 7810.
13. Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B Stremmel W (2004) Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 53, 735 743.
14. Valore EV Ganz T (2008) Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. Blood Cells Mol Dis 40, 132 138.
15. Lee P (2008) Commentary to: 'Post-translational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin', by Erika Valore and Tomas Ganz. Blood Cells Mol Dis 40, 139 140.
16. Hook VY, Azaryan AV, Hwang SR Tezapsidis N (1994) Proteases and the emerging role of protease inhibitors in prohormone processing. FASEB J 8, 1269 1278.
17. De DI, Ward DM, Musci G Kaplan J (2006) Iron overload due to mutations in ferroportin. Haematologica 91, 92 95.
18. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090 2093.
19. De DI, Ward DM, Langelier C, Vaughn MB, Nemeth E, Sundquist WI, Ganz T, Musci G Kaplan J (2007) The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 18, 2569 2578.
20. Mena NP, Esparza A, Tapia V, Valdes P Nunez MT (2008) Hepcidin inhibits apical iron uptake in intestinal cells. Am J Physiol Gastrointest Liver Physiol 294, G192 G198.
21. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A Ganz T (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101, 2461 2463.
22. Wrighting DM Andrews NC (2006) Interleukin-6 induces hepcidin expression through STAT3. Blood 108, 3204 3209.
23. Verga Falzacappa MV, Vujic SM, Kessler R, Stolte J, Hentze MW Muckenthaler MU (2007) STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109, 353 358.
24. Fleming RE (2007) Hepcidin activation during inflammation: make it STAT. Gastroenterology 132, 447 449.
25. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A Vaulont S (2002) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110, 1037 1044.
26. Leong WI Lonnerdal B (2004) Hepcidin, the recently identified peptide that appears to regulate iron absorption. J Nutr 134, 1 4.
27. Ganz T (2006) Hepcidin - a peptide hormone at the interface of innate immunity and iron metabolism. Curr Top Microbiol Immunol 306, 183 198.
28. Weinberg ED (2008) Iron availability and infection. Biochim Biophys Acta, doi :.
29. Paradkar PN, De DI, Durchfort N, Zohn I, Kaplan J Ward DM (2008) Iron depletion limits intracellular bacterial growth in macrophages. Blood 112, 866 874.
30. Collins HL (2008) Withholding iron as a cellular defence mechanism - friend or foe? Eur J Immunol 38, 1803 1806.
31. Valenti L, Dongiovanni P, Piperno A, Fracanzani AL, Maggioni M, Rametta R, Loria P, Casiraghi MA, Suigo E, Ceriani R et al. (2006) Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage. Hepatology 44, 857 864.
32. Fink S Schilsky ML (2007) Inherited metabolic disease of the liver. Curr Opin Gastroenterol 23, 237 243.
33. Nagashima M, Kudo M, Chung H, Ishikawa E, Hagiwara S, Nakatani T Dote K (2006) Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Hepatol Res 36, 288 293.
34. Jayaranee S, Sthaneshwar P Sokkalingam S (2009) Serum prohepcidin concentrations in rheumatoid arthritis. Pathology 41, 178 182.
35. Koca SS, Isik A, Ustundag B, Metin K Aksoy K (2008) Serum pro-hepcidin levels in rheumatoid arthritis and systemic lupus erythematosus. Inflammation 31, 146 153.
36. Jaroszewicz J, Rogalska M Flisiak R (2008) Serum prohepcidin reflects the degree of liver function impairment in liver cirrhosis. Biomarkers 13, 478 485.
37. Constante M, Jiang W, Wang D, Raymond VA, Bilodeau M Santos MM (2006) Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation. Am J Physiol Gastrointest Liver Physiol 291, G229 G237.
38. Oates PS (2007) The role of hepcidin and ferroportin in iron absorption. Histol Histopathol 22, 791 804.
39. Kemna EH, Kartikasari AE, van Tits LJ, Pickkers P, Tjalsma H Swinkels DW (2008) Regulation of hepcidin: insights from biochemical analyses on human serum samples. Blood Cells Mol Dis 40, 339 346.
40. Hochepied T, Berger FG, Baumann H Libert C (2003) Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev 14, 25 34.
41. Weiss G (2008) Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta, doi : (in press).
42. Kartikasari AE, Roelofs R, Schaeps RM, Kemna EH, Peters WH, Swinkels DW Tjalsma H (2008) Secretion of bioactive hepcidin-25 by liver cells correlates with its gene transcription and points towards synergism between iron and inflammation signaling pathways. Biochim Biophys Acta 1784, 2029 2037.